Rangeley Capital, LLC

NEW CANAAN, CT · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$72.7M2026 Q3+ $1.3M options (notional, not included)
Positions135
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.29.6%

Rangeley Capital, LLC reported 135 positions worth $72.7M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: DRVN (5.3%). Biggest move: exit RVMDW ($4.7M).

10 / 135 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 DRVNDriven Brands$3.9M5.27%330,500——-7.1%
▸ 2 PRTAProthena Corp Public$3.0M4.02%354,748——-4.9%
▸ 3 STHOStar$2.5M3.37%291,374———
▸ 4 ABUSArbutus Biopharma$2.4M3.23%500,000——-14.4%
▸ 5 SEGSeaport Entertainment$1.9M2.60%84,000——-10.4%
▸ 6 ABVXAbivax S.A.$1.8M2.48%18,500———
▸ 7 RLYBRallybio$1.7M2.28%97,948——-10.3%
▸ 8 GDOTGreen Dot$1.6M2.19%131,594——-4.2%
▸ 9 MNROMonro$1.6M2.10%111,000——-24.7%
▸ 10 IBITiShares Bitcoin Trust$1.5M2.04%31,900——-22.3%

Pro Feature

The remaining 125 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Rangeley Capital, LLC hold as of Q3 2026?

Rangeley Capital, LLC reported 135 positions worth $72.7M in its Q3 2026 13F filing. Largest positions: DRVN (5.3%), PRTA (4.0%), STHO (3.4%), ABUS (3.2%) and SEG (2.6%).

What did Rangeley Capital, LLC buy in Q3 2026?

New positions: CODI, FBIN, FRMI, LNTH and BBWI (32 in all). Added to: ANAB, IBIT, SEER, ABVX and SITC (26 in all).

What did Rangeley Capital, LLC sell in Q3 2026?

Reduced: DRVN, GRND, SEG, DK and JANX (44 in all). Sold out entirely: RVMDW, ECHO, DSGR, TBPH and RVMD (80 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.